Is it possible to imagine a world free from Autism? Or practically a world where medical feats help to treat Autism back to normalcy? This wishful thinking might just translate into reality. Thanks to the research on regenerative medicines using cord blood cells. Recently, a group of researchers have been working to discover that cord blood cells might have a way to cure Autism Spectrum Disorder (ASD). It has been observed that umbilical cord blood can be instrumental in repairing the body in ASD, which further holds promise for a probable treatment.
Many Americans have been resorting to this to heal ASD in their child. The brand-new US clinical trial is said to be the very first to get US Food and Drug Administration’s approval. Administered and managed by Dr. Mansoor Michael Chez, the Director of Pediatric Neurology, Sutter Medical Center, a team of researchers sometime back had published the outcome of a Phase II Clinical Trial that looked into the effectiveness and security of autologous umbilical cord blood cells for autistic children that deployed a placebo- managed, double-blind design. Back in 2017, these medical researchers at Duke University also published a Phase I security trial assessing autologous umbilical cord blood in autistic children. The emphasis on cord blood cells being a potential cellular therapy accompanied with favourable findings from past clinical studies, promises a brighter future in treating ASD. CBR in its initiative to explore the potential of stem cells has offered institutional funding for Stutter clinical researchers.
The Scope of Newborn Stem Cells
The emphasis on cord blood cells being effective in treating ASD stems from its innate benefits. Cells from umbilical cord blood have set of benefits such as:
· Anti-inflammatory properties – Research has revealed that stem cells possess the capacity to normalize inflammation and migrate to the location of neurologic injury.
· Secure and available – Blood from the umbilical cord is collected easily when a baby is born and can be stored indefinitely for any future use by a close family member or the newborn donor
· Bystander effect- It is said that infused stem cells secrete factors which regenerates the body’s innate healing mechanism in and around a surrounding tissue through paracrine signalling, which is also called the bystander effect.
ASD Research Kickstarts
The very first clinical research making use of the blood from umbilical cord that was earlier banked from the autistic child was completed recently. The children between the age group 2 and 6 who had ASD were researched on for this study. The objective of this trial was to evaluate if blood from the umbilical cord was a secure means to use it on these children and record any health improvement that might occur in a year. This children team was given one dose of stem cells via intravenous infusion and the effects were observed. This study paved the foundation for other advanced studies to commence in future. It proved that cord blood cell was a secure therapy mode when transferred as an infusion. It also recognized certain symptoms that could have been influenced.
These clinical trials highlight the significance of banking an infant’s stem cells. It also offers valid reasons as to why families should spend the dear amount in cord blood banking processes. Modern day medicine scene is at an ongoing evolution stage. And cord blood cell researches carry on to come with new and revolutionary treatment choices for a wide range of medical conditions that were previously said to be incurable. Clinical trials understanding the use of cord blood cells to cure Type 1 Diabetes, cerebral palsy and stroke are already in progress. The chance of ASD being treatable with stem cell is a huge boon that the medical world can gift humanity.